DK0731709T3 - Neutrofilinhibitorer fra nematoder - Google Patents

Neutrofilinhibitorer fra nematoder

Info

Publication number
DK0731709T3
DK0731709T3 DK93911273T DK93911273T DK0731709T3 DK 0731709 T3 DK0731709 T3 DK 0731709T3 DK 93911273 T DK93911273 T DK 93911273T DK 93911273 T DK93911273 T DK 93911273T DK 0731709 T3 DK0731709 T3 DK 0731709T3
Authority
DK
Denmark
Prior art keywords
nematodes
compositions
neutrophil
neutrophil inhibitors
inhibitors
Prior art date
Application number
DK93911273T
Other languages
Danish (da)
English (en)
Inventor
George Phillip Vlasuk
Matthew Moyle
David Lee Foster
Original Assignee
Corvas Int Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corvas Int Inc filed Critical Corvas Int Inc
Application granted granted Critical
Publication of DK0731709T3 publication Critical patent/DK0731709T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
    • C07K14/4354—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from nematodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F02—COMBUSTION ENGINES; HOT-GAS OR COMBUSTION-PRODUCT ENGINE PLANTS
    • F02B—INTERNAL-COMBUSTION PISTON ENGINES; COMBUSTION ENGINES IN GENERAL
    • F02B75/00—Other engines
    • F02B75/02—Engines characterised by their cycles, e.g. six-stroke
    • F02B2075/022—Engines characterised by their cycles, e.g. six-stroke having less than six strokes per cycle
    • F02B2075/027—Engines characterised by their cycles, e.g. six-stroke having less than six strokes per cycle four

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK93911273T 1992-05-11 1993-05-11 Neutrofilinhibitorer fra nematoder DK0731709T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US88172192A 1992-05-11 1992-05-11
US99697292A 1992-12-24 1992-12-24
PCT/US1993/004502 WO1993023063A1 (en) 1992-05-11 1993-05-11 Novel neutrophil inhibitors

Publications (1)

Publication Number Publication Date
DK0731709T3 true DK0731709T3 (da) 2002-02-11

Family

ID=27128632

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93911273T DK0731709T3 (da) 1992-05-11 1993-05-11 Neutrofilinhibitorer fra nematoder

Country Status (13)

Country Link
US (1) US6756211B1 (de)
EP (1) EP0731709B1 (de)
JP (1) JP3509860B2 (de)
AT (1) ATE207498T1 (de)
AU (1) AU687737B2 (de)
CA (1) CA2135390A1 (de)
DE (1) DE69331018T2 (de)
DK (1) DK0731709T3 (de)
ES (1) ES2168095T3 (de)
MX (1) MX9302750A (de)
NZ (3) NZ252591A (de)
PT (1) PT731709E (de)
WO (1) WO1993023063A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1749534B1 (de) 1997-12-31 2013-08-21 University Of Iowa Research Foundation Verwendung von parasitären biologischen Wirkstoffen zur Vorbeugung und Kontrolle von chronisch-entzündlichen Darmerkrankungen
EP1186303A3 (de) * 2000-09-06 2003-12-10 Pfizer Products Inc. Ein Neutrophilhemmender Faktor und ein selektive NMDA-NR2B Rezeptor Antagonisten enthaltende Kombinationspräparate zur Behandlung von Schlaganfällen und traumatischen Gehirnschäden
WO2006062776A2 (en) * 2004-11-29 2006-06-15 The Regents Of The University Of California Hydroxyapatite-binding peptides for bone growth and inhibition
DE102007021199B4 (de) * 2006-07-17 2016-02-11 Evonik Degussa Gmbh Zusammensetzungen aus organischem Polymer als Matrix und anorganischen Partikeln als Füllstoff, Verfahren zu deren Herstellung sowie deren Verwendung und damit hergestellte Formkörper
CA2866819C (en) 2012-03-13 2022-01-04 James Cook University Method for treating inflammation
JP2016532456A (ja) 2013-09-18 2016-10-20 ジェームス・クック・ユニバーシティー 改変型抗炎症性タンパク質及び使用方法
EP3554257B1 (de) 2016-12-15 2023-07-12 Société des Produits Nestlé S.A. Zusammensetzungen und verfahren zur modulation von weissen blutkörperchen oder neutrophilen in einem haustier

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4431739A (en) * 1979-11-05 1984-02-14 Genentech, Inc. Transformant bacterial culture capable of expressing heterologous protein
US4438032A (en) * 1981-01-30 1984-03-20 The Regents Of The University Of California Unique T-lymphocyte line and products derived therefrom
US5019648A (en) * 1987-07-06 1991-05-28 Dana-Farber Cancer Institute Monoclonal antibody specific for the adhesion function domain of a phagocyte cell surface protein
DE68923107T2 (de) * 1988-02-26 1996-01-18 Biogen Inc DNA-Sequenzen, rekombinante DNA-Moleküle und Verfahren zur Herstellung von Lipocortin III, IV, V, und VI.
US5256642A (en) * 1988-04-01 1993-10-26 The Johns Hopkins University Compositions of soluble complement receptor 1 (CR1) and a thrombolytic agent, and the methods of use thereof
JPH05504470A (ja) * 1989-10-20 1993-07-15 ニューイングランド・メディカル・センター・ホスピタルズ・インコーポレーテッド Ｐａｄｇｅｍを介した細胞結合の阻害
US5314992A (en) * 1991-11-25 1994-05-24 Trustees Of Dartmouth College Lipocortin-1 receptor protein and its uses

Also Published As

Publication number Publication date
CA2135390A1 (en) 1993-11-25
NZ505450A (en) 2002-02-01
PT731709E (pt) 2002-04-29
MX9302750A (es) 1994-02-28
JPH07508177A (ja) 1995-09-14
EP0731709A4 (de) 1997-06-11
WO1993023063A1 (en) 1993-11-25
NZ252591A (en) 1997-02-24
ATE207498T1 (de) 2001-11-15
AU687737B2 (en) 1998-03-05
US6756211B1 (en) 2004-06-29
DE69331018D1 (de) 2001-11-29
ES2168095T3 (es) 2002-06-01
AU4246493A (en) 1993-12-13
EP0731709A1 (de) 1996-09-18
DE69331018T2 (de) 2002-06-13
EP0731709B1 (de) 2001-10-24
JP3509860B2 (ja) 2004-03-22
NZ299623A (en) 2000-11-24

Similar Documents

Publication Publication Date Title
CA2129339A1 (en) Inhibitors of thrombosis
EP0684830A4 (de) Inhibitoren gegen thrombose.
BG101841A (bg) Инхибитори на клетъчна адхезия
TR199801168T2 (xx) �nterleukin-1 beta d�n��t�r�c� enzim inhibit�rleri.
GEP20012446B (en) Inhibitors of Interleukin- 1β Converting Enzyme
ES2194986T3 (es) Compuestos de carbonil-piperazinilo y piperidinilo que inhiben la farnesil-protein-transferasa.
DE69833654D1 (de) Biarylalkansäuren in der verwendung als zelladhäsionsinhibitoren
BG103193A (en) Cellular adhesion inhibitors
FI980033A7 (fi) Solujen kiinnittymisen inhibiittoreita
DE69414115D1 (de) Vitamin d analoge
ES2103305T3 (es) Produccion de inhibidor de interleuquina-1 humana recombinada.
ES2106965T3 (es) Nuevas 4-aza-5alfa-androstan-3-onas 7beta-sustituidas como inhibidores de 5alfa-reductasa.
DE69132040D1 (de) Wachstumsfaktor II für vaskuläre Endothelzellen
KR950700323A (ko) 엔케팔리나제 및 안지오텐신 전환 효소의 억제제로서 유용한 아미노아세틸머캅토아세틸아미드 유도체(Aminoacetylmercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ACE)
NO20004053D0 (no) Glukokortikoid-selektive antiinflammatoriske midler
TR200002345T2 (tr) Glukokortikoit seçiçi antienflamatuar ajanlar
EE200100355A (et) Rakkude adhesiooni inhibeerivad põletikuvastased ja immunosupressiivsed ühendid
FI951298A0 (fi) 2-amino-4-fenyyli-4-oksovoihappojohdannaiset, joilla on kynureninaasia ja/tai kynureniini-3-hydroksylaasia inhiboiva aktiivisuus
ATE261932T1 (de) Inhibitoren der alpha-4 beta-1 vermittelten zelladhäsion
DK0731709T3 (da) Neutrofilinhibitorer fra nematoder
MX9701776A (es) Uso de factores de crecimiento similares a insulina i y ii para la inhibicion de la respuesta inflamatoria.
DE68925032D1 (de) Leukozyten-adhäsions-inhibitor.
AU8128691A (en) Hydrochloric acid donors as stabilizers for ACE inhibitor compositions
NO943126L (no) 3-alkyloksy-, aryloksy- eller arylalkyloksybenzo-[bÅtiofen-2-karboksamider som hemmere av celleadhesjon
ATE204478T1 (de) Inhibierung von leukozytenadhäsion